Literature DB >> 18613644

Activation of NK cells by extracellular heat shock protein 70 through induction of NKG2D ligands on dendritic cells.

Yi Qiao1, Bei Liu, Zihai Li.   

Abstract

We have previously reported that heat shock protein 70 (HSP70) vaccination induced natural killer (NK) cell activity in patients with chronic myelogenous leukemia (CML). In this study, HSP70 of both autologous and allogeneic origin was found to stimulate IFN-gamma production from peripheral blood mononuclear cells of CML patients, as well as of normal subjects. Further investigations demonstrated that the activity of HSP70 was dependent on both NK cells and dendritic cells (DCs). HSP70 did not induce significant IFN-gamma production from either NK cells or DCs alone. Mechanistically, we found that HSP70-mediated DC-NK cell crosstalk required cell-cell contact, which could be inhibited completely by neutralizing antibody against NK activating receptor NKG2D. The significance of NKG2D was further corroborated by the finding that HSP70 induced the expression of an NKG2D ligand, the MHC class I chain-related protein A (MICA), on DCs; HSP70-augmented IFN-gamma release was abrogated by antibody against MICA. Thus extracellular HSP70, released during either stress or inflammatory cell death, may serve as a critical link between NK and DCs in mounting immune responses against infections, cancers and self-antigens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18613644      PMCID: PMC2935777     

Source DB:  PubMed          Journal:  Cancer Immun        ISSN: 1424-9634


  50 in total

1.  CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

Authors:  S Basu; R J Binder; T Ramalingam; P K Srivastava
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

2.  A single amino acid substitution causes loss of expression of a MICA allele.

Authors:  Z Li; V Groh; R K Strong; T Spies
Journal:  Immunogenetics       Date:  2000-03       Impact factor: 2.846

3.  Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway.

Authors:  S Basu; R J Binder; R Suto; K M Anderson; P K Srivastava
Journal:  Int Immunol       Date:  2000-11       Impact factor: 4.823

Review 4.  Immunotherapy of human cancer: lessons from mice.

Authors:  P K Srivastava
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

5.  Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.

Authors:  P K Srivastava; N S Jaikaria
Journal:  Methods Mol Biol       Date:  2001

6.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Authors:  D Cosman; J Müllberg; C L Sutherland; W Chin; R Armitage; W Fanslow; M Kubin; N J Chalupny
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

7.  Role of scavenger receptors in the binding and internalization of heat shock protein 70.

Authors:  Jimmy R Thériault; Hideki Adachi; Stuart K Calderwood
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

Review 8.  HSPPC-96: a personalised cancer vaccine.

Authors:  M M Caudill; Z Li
Journal:  Expert Opin Biol Ther       Date:  2001-05       Impact factor: 4.388

Review 9.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

10.  Reciprocal activating interaction between natural killer cells and dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Carla Nisii; Viviana Marchesini; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  21 in total

1.  Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy.

Authors:  A Bajor; S Tischer; C Figueiredo; M Wittmann; S Immenschuh; R Blasczyk; B Eiz-Vesper
Journal:  Clin Exp Immunol       Date:  2011-06-03       Impact factor: 4.330

Review 2.  Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.

Authors:  F M Hofman; A Stathopoulos; C A Kruse; T C Chen; V E J C Schijns
Journal:  Anticancer Agents Med Chem       Date:  2010-07       Impact factor: 2.505

3.  Pediatric Sepsis - Part V: Extracellular Heat Shock Proteins: Alarmins for the Host Immune System.

Authors:  John S Giuliano; Patrick M Lahni; Hector R Wong; Derek S Wheeler
Journal:  Open Inflamm J       Date:  2011-10-07

4.  Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.

Authors:  Sebastian P Haen; Cécile Gouttefangeas; Diethard Schmidt; Andreas Boss; Stephan Clasen; Alexandra von Herbay; Bora Kosan; Hermann Aebert; Philippe L Pereira; Hans-Georg Rammensee
Journal:  Cell Stress Chaperones       Date:  2011-03-26       Impact factor: 3.667

5.  Serum Heat Shock Protein 70, as a Potential Biomarker for Small Cell Lung Cancer.

Authors:  Madaras Balázs; Horváth Zsolt; Gráf László; Gálffy Gabriella; Tamási Lilla; Ostoros Gyula; Döme Balázs; Mórocz Éva; Bártfai Zoltán; Prohászka Zoltán; Kocsis Judit
Journal:  Pathol Oncol Res       Date:  2016-10-04       Impact factor: 3.201

6.  Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Elizabeth Alvarez-Connelly; Jessica Simon; Lucia M Mauro; Javier Guzman; George Elgart; Lawrence A Schachner; Juan Chen; Lisa R Plano; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2010-06-27       Impact factor: 3.667

Review 7.  Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.

Authors:  Danilo Perrotti; Giovannino Silvestri; Lorenzo Stramucci; Justine Yu; Rossana Trotta
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 8.  Ovarian cancer immunotherapy: opportunities, progresses and challenges.

Authors:  Bei Liu; John Nash; Carolyn Runowicz; Helen Swede; Richard Stevens; Zihai Li
Journal:  J Hematol Oncol       Date:  2010-02-10       Impact factor: 17.388

Review 9.  Tumour vaccine approaches for CNS malignancies: progress to date.

Authors:  Johnathan D Ebben; Brandon G Rocque; John S Kuo
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 10.  Promoting Neuronal Tolerance of Diabetic Stress: Modulating Molecular Chaperones.

Authors:  S M Emery; R T Dobrowsky
Journal:  Int Rev Neurobiol       Date:  2016-04-05       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.